Table 3.
T lymphocyte activation (%).
| Sham | Saline | A100 | A200 | A400 | |
|---|---|---|---|---|---|
| Spleen | |||||
| CD69+ Th cells | 10.4 ± 0.6 | 12.4 ± 1.2 | 14.5 ± 0.9∗ | 15.3 ± 0.8∗ | 16.6 ± 1.0∗ |
| CD69+ Tc cells | 4.6 ± 0.4 | 7.4 ± 1.4 | 7.0 ± 0.8 | 8.1 ± 1.5 | 8.3 ± 2.1 |
| Peyer's patches | |||||
| CD69+ Th cells | 53.6 ± 2.5 | 38.3 ± 3.2∗ | 37.7 ± 2.5∗ | 45.6 ± 2.3 | 46.0 ± 4.0 |
| CD69+ Tc cells | 42.8 ± 6.2 | 45.3 ± 6.8 | 43.3 ± 6.3 | 42.5 ± 5.4 | 46.1 ± 5.7 |
T helper (Th) and cytotoxic T (Tc) cells were, respectively, identified by CD4+CD8− and CD4−CD8+ cells among CD3ε-positive cells using a flow cytometer. Activated T cells were determined by the expression of CD69 on T-cell subsets. Values are presented as the mean ± SEM. ∗Significantly different from the sham group (p < 0.05).
A100, A200, and A400, respectively, indicate treatment with 100, 200, and 400 mg Astragalus polysaccharides/kg of body weight.